Germany / Japan / United States / Brazil / United Kingdom / /
Currency
pence / / /
Event
FDA Phase / /
Facility
Hospital Pharmacy / /
IndustryTerm
sample solution / main degradation products / pharmaceutical formulation / extractive solution / active pharmaceutical / delivery technology / chemical class / drug product / dilution protocol / bulk pharmaceuticals / final solution / pharmaceutical analysis / final products / likely degradation products / osmotic systems / osmotic pump delivery systems / paliperidone standard solution / placebo solution / reference solutions / degradation products / Basic and acidic media / system software / pharmaceutical delivery system / extended-release tablet solutions / pharmaceutical grade / oral therapeutic systems / retail store / reference standard solution / drug using acidic solutions / paliperidone reference solutions / chemical properties / minor products / sample solutions / drug delivery technologies / paliperidone sample solution / drug products / chemicals / control solution / /
MedicalCondition
PDA / MS / attention-deficit/hyperactivity disorder / schizoaffective disorder presenting / schizophrenia / chronic treatment / chronic low back pain / related disorders / ective Disorders / /
MedicalTreatment
Drug delivery system / controlled-release preparations / /
Organization
United States Food and Drug Administration / US Food and Drug Administration / Universidade Federal do Rio Grande do Sul / Pharmaceutical Association / /
Person
C. Fente Sampayo / B. Carbonnier / Nova Etica / A. Namera / Andreas S. L. Mendez / /